Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

Vaccine. 2002 Jul 26;20(23-24):2921-7. doi: 10.1016/s0264-410x(02)00219-0.

Abstract

The immune response against early regulatory proteins of simian- and human immunodeficiency virus (SIV, HIV) has been associated with a milder course of infection. Here, we directly compared vaccination with Tat/Rev versus Pol/Gag. Challenge infection with SIVmac32H (pJ5) suggested that vaccination with Tat/Rev induced cellular immune responses that enabled cynomolgus macaques to more efficiently control SIV replication than the vaccine-induced immune responses against Pol/Gag. Vaccination with Tat/Rev resulted in reduced plasma SIV loads compared with control (P=0.058) or Pol/Gag-vaccinated (P=0.089) animals, with undetectable plasma viral loads in two of the four Tat/Rev-vaccinated animals. Therefore, the results warrant further investigation of the early regulatory proteins and their potential for vaccination against HIV.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Viral / biosynthesis
  • Antibodies, Viral / blood
  • Base Sequence
  • Gene Products, gag / genetics
  • Gene Products, gag / immunology
  • Gene Products, pol / genetics
  • Gene Products, pol / immunology
  • Gene Products, rev / genetics
  • Gene Products, rev / immunology
  • Gene Products, tat / genetics
  • Gene Products, tat / immunology
  • Humans
  • Immunity, Cellular
  • Macaca fascicularis
  • RNA, Viral / blood
  • RNA, Viral / genetics
  • SAIDS Vaccines / genetics
  • SAIDS Vaccines / immunology*
  • Simian Acquired Immunodeficiency Syndrome / immunology
  • Simian Acquired Immunodeficiency Syndrome / prevention & control
  • Simian Acquired Immunodeficiency Syndrome / virology
  • Simian Immunodeficiency Virus / genetics
  • Simian Immunodeficiency Virus / immunology*
  • Viremia / immunology
  • Viremia / prevention & control
  • Viremia / virology

Substances

  • Antibodies, Viral
  • Gene Products, gag
  • Gene Products, pol
  • Gene Products, rev
  • Gene Products, tat
  • RNA, Viral
  • SAIDS Vaccines